Sector: Healthcare | Industry: Pharmaceuticals |
Company Contact | |
Address: | 2207 90B Street Sw LEDUC AB T6X 1V8 |
Tel: | N/A |
Website: | https://www.auroramj.com |
IR: | See website |
Key People | ||
Miguel Martin Chief Executive Officer, Director | Simona King Chief Financial Officer | Nathalie Clark Executive Vice President, General Counsel, Company Secretary |
Lori Schick Executive Vice President - Human Resources | Andre Jerome Executive Vice President - Global Business Development | Alex Miller Executive Vice President - Operations and Supply Chain |
Business Overview |
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company's segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets. |
Financial Overview |
For the nine months ended 31 December 2023, Aurora Cannabis Inc revenues increased 83% to C$202.9M. Net loss before extraordinary items decreased 63% to C$43.1M. Revenues reflect Cannabis segment increase of 90% to C$148.5M, Canada (Country) segment increase of 96% to C$172M, European Union (Region) segment increase of 83% to C$30.2M. Lower net loss reflects Unrealized gain on changes in fair value increase from C$27.4M to C$86.1M (income). |
Employees: | 1,130 as of Mar 31, 2023 |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $343.81M as of Dec 31, 2023 |
Annual revenue (TTM): | $266.97M as of Dec 31, 2023 |
EBITDA (TTM): | -$134.82M as of Dec 31, 2023 |
Net annual income (TTM): | -$125.07M as of Dec 31, 2023 |
Free cash flow (TTM): | -$86.25M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 54,539,376 as of Feb 21, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |